Philips publishes its Annual Report 2022
21 Février 2023 - 08:01AM
GlobeNewswire Inc.
Philips publishes its Annual Report 2022
February 21, 2023Amsterdam, the Netherlands –
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health
technology, today published its Annual Report 2022. Philips’ Annual
Report 2022 will be on the agenda of the Annual General Meeting of
Shareholders (AGM), to be held on May 9, 2023. The convocation
notice and the agenda, including explanatory notes, for the AGM
2023 will be published in due course.
2022 was a very disappointing year for Philips and its
stakeholders, and as recently announced, the company is taking firm
action to strengthen patient safety and quality, improve its
execution and step up performance with urgency in 2023.
The 2022 Remuneration Report, as included in the Annual Report
2022, will also be on the agenda of the AGM 2023. In his letter to
Philips’ stakeholders, the Chairman of the Remuneration Committee
explains that the Committee has been very mindful of the
shareholder sentiment and the advisory vote regarding the 2021
Remuneration Report cast at the AGM 2022. The Remuneration
Committee reports on how it reached out to the company’s
shareholders immediately after the AGM 2022, and how the feedback
received from shareholders in the second half of 2022 has been
addressed.
The Remuneration Report furthermore explains how the
remuneration in respect of the year 2022 has been impacted by
Philips’ performance in 2022. In this context, and to further align
with the company performance, as well as the sentiment and negative
experience of the company’s shareholders and other stakeholders,
the Supervisory Board and current Board of Management have jointly
concluded that it was appropriate to waive any 2022 Annual
Incentive (AI) pay-out and any vesting of the 2020 Long-term
Incentive (LTI) grant of the members of the Board of
Management.
Philips filed the Annual Report 2022 with the Netherlands
Authority for the Financial Markets (AFM) in European Single
Electronic Format (ESEF) and expects to file the report on Form
20-F with the U.S. Securities and Exchange Commission later today
(www.sec.gov).
The Annual Report 2022 (in ESEF and on Form 20-F) is available
to shareholders and other interested parties at
www.results.philips.com. A printed copy can be obtained free of
charge upon written request to the following email address:
annual.report@philips.com.For further information, please
contact:
Ben ZwirsPhilips Global Press OfficeTel.: +31 6 1521 3446E-mail:
ben.zwirs@philips.com
Derya GuzelPhilips Investor RelationsTel.: +31 20 59
77055E-mail: derya.guzel@philips.com
About Royal PhilipsRoyal Philips (NYSE: PHG,
AEX: PHIA) is a leading health technology company focused on
improving people's health and well-being through meaningful
innovation. Philips’ patient- and people-centric innovation
leverages advanced technology and deep clinical and consumer
insights to deliver personal health solutions for consumers and
professional health solutions for healthcare providers and their
patients in the hospital and the home. Headquartered in the
Netherlands, the company is a leader in diagnostic imaging,
ultrasound, image-guided therapy, monitoring and enterprise
informatics, as well as in personal health. Philips generated 2022
sales of EUR 17.8 billion and employs approximately 77,000
employees with sales and services in more than 100 countries. News
about Philips can be found at www.philips.com/newscenter.
Forward-looking statements
This release contains certain forward-looking statements with
respect to the financial condition, results of operations and
business of Philips and certain of the plans and objectives of
Philips with respect to these items. Examples of forward-looking
statements include statements made about the strategy, estimates of
sales growth, future EBITA, future developments in Philips’ organic
business and the completion of acquisitions and divestments. By
their nature, these statements involve risk and uncertainty because
they relate to future events and circumstances and there are many
factors that could cause actual results and developments to differ
materially from those expressed or implied by these statements.
Koninklijke Philips NV (EU:PHIA)
Graphique Historique de l'Action
De Mai 2023 à Mai 2023
Koninklijke Philips NV (EU:PHIA)
Graphique Historique de l'Action
De Mai 2022 à Mai 2023